In partnership with the Icahn School of Medicine at Mount Sinai Science magazine recently published a supplement titled “The Frontiers of Medical Research.” The supplement includes 17 articles prepared by Mount Sinai researchers, physicians, and educators that summarize the most promising current breakthroughs and directions for medical research and training.

ConduITS – the Institutes for Translational Sciences and the Mount Sinai Health System CTSA which is dedicated to streamlining and centralizing infrastructure to accelerate translational research devotes part of its efforts to addressing health disparities by leveraging Mount Sinai’s unique infrastructure to integrate exposomics resources into precision medicine and public health.

Included in the Science magazine supplement is an article, which discusses “Integrating Exposomics into Precision Medicine and Public Health”. The article is co-authored by Robert O. Wright MD, MPH, Ethel H Wise Professor and Chair Department of Environmental Medicine & Public Health and Director, Institute for Exposomic Research, Kecia N. Carroll, MD, MPH, Division Chief of the Division of General Pediatrics in the Jack and Lucy Clark Department of Pediatrics at Mount Sinai and Rosalind J. Wright, MD, MPH, Horace W. Goldsmith Professor of Pediatrics, Kravis Children’s Hospital, Dean for Translational Biomedical Sciences and the Director of ConduITS (the Mount Sinai Health System CTSA).

The technology to measure the exposome is far more advanced than many researchers may realize, given that it has arisen largely in parallel silos. At Mount Sinai, our Institute for Exposomic Research brings together the broad intellectual and technological expertise that moves us toward unifying exposomics into a single, cohesive field.(1).

Exposomics is rapidly evolving and represents a change in the philosophy of environmental research as it moves toward discovery. Data-driven research has led to an explosion of discoveries in genomics, proteomics, and epigenomics; exposomics is the next “omics” wave, and with it, we can expand precision medicine to more fully understand patient susceptibility. For further inquiries or information, please place a Research 411 ticket here.

  1. Robert O. Wright, Kecia N. Carroll, Rosalind J. Wright, Integrating Exposomics into Precision Medicine and Public Health, in The Frontiers of Medical Research (Science/AAAS, Washington, DC, 2021), p.14-16.

ConduITS is supported by NCATS of the NIH’s CTSA Program. Any use of CTSA-supported resources requires citation of grant number UL1TR001433 awarded to ISMMS in the acknowledgment section of every publication resulting from this support. Adherence to the NIH Public Access Policy is also required.